GEM FORLAB S.r.L. Alternatives & Competitors
8 companies similar to GEM FORLAB S.r.L. — Thinking outside the box, we mix different skills to create the perfect solution
Companies similar to GEM FORLAB S.r.L.
CYANAGEN S.R.L.
DNA/RNA Extraction kits, Chemiluminescence Substrates for Wester blotting & Fluorescent Re...
Syncell Inc
Enabling Microscopy-Guided Subcellular Proteomic Discovery
Alta Biotech, LLC.
Specializing in plasmid DNA production and services for life science research
Track all GEM FORLAB S.r.L. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
DNA Script
Transforming how molecular biology translates to human health, personalized medicine and s...
ABC Laboratories
A Eurofins Company
Kerafast, part of Absolute Biotech
We make unique laboratory-made research tools easily accessible to the global scientific c...
Synthego
Your Partner in CRISPR & Molecular Diagnostics
About GEM FORLAB S.r.L.
GEM FORLAB S.r.L. is a company that continues the experience of ABLE Biosciences as a global provider of scientific technology and services to the Life Science industry. They offer solutions to companies of all sizes through three technology areas: Organic Chemistry, Mass Spectrometry & Proteomics, and Cell and Molecul...
Life Science, Scientific Technology, Global Provider, Organic Chemistry, Mass Spectrometry, Proteomics, Cell Biology, Molecular Biology, Immunoassay, GLP Certification, GCP Compliance, Bioanalytics, Biochemistry, Molecular Imaging
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches GEM FORLAB S.r.L. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at GEM FORLAB S.r.L. on 14 Sep 2024. The 8 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.